These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 3490445

  • 1. Immunoresistant metastatic tumor variants can re-express their tumor antigen after treatment with DNA methylation-inhibiting agents.
    Altevogt P, von Hoegen P, Schirrmacher V.
    Int J Cancer; 1986 Nov 15; 38(5):707-11. PubMed ID: 3490445
    [Abstract] [Full Text] [Related]

  • 2. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P, Leidig S, Heckl-Oestreicher B.
    Cancer Res; 1984 Nov 15; 44(11):5305-13. PubMed ID: 6333273
    [Abstract] [Full Text] [Related]

  • 3. Antigenic variation in cancer metastasis: immune escape versus immune control.
    Schirrmacher V, Fogel M, Russmann E, Bosslet K, Altevogt P, Beck L.
    Cancer Metastasis Rev; 1982 Nov 15; 1(3):241-74. PubMed ID: 6985248
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response.
    Von Hoegen P, Weber E, Schirrmacher V.
    Eur J Immunol; 1988 Aug 15; 18(8):1159-66. PubMed ID: 2970967
    [Abstract] [Full Text] [Related]

  • 10. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 15; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 11. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R, Luescher B, Cerottini JC, MacDonald HR.
    J Immunol; 1985 Aug 15; 135(2):892-9. PubMed ID: 2409156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ, Wheelock EF.
    Cancer Res; 1982 Sep 15; 42(9):3607-16. PubMed ID: 6179603
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V, Schild HJ, Gückel B, von Hoegen P.
    Immunol Cell Biol; 1993 Aug 15; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [Abstract] [Full Text] [Related]

  • 19. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V, Bosslet K, Shantz G, Clauer K, Hübsch D.
    Int J Cancer; 1979 Feb 15; 23(2):245-52. PubMed ID: 83969
    [Abstract] [Full Text] [Related]

  • 20. Detection of tumour-associated transplantation antigens by syngeneic cytotoxic T lymphocytes after fusion of tumour cell membrane vesicles to recipient cells.
    Altevogt P.
    Scand J Immunol; 1984 Sep 15; 20(3):255-60. PubMed ID: 6387890
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.